Nitric Oxide and Transfusion Therapy for Sickle Cell Patients With Pulmonary Hypertension

Clinical trial NCT00023296 · COMPLETED

Trial details

NCT number: NCT00023296
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Sickle Cell Anemia Pulmonary Hypertension

Start date: 2001-07-27
Primary completion: 2006-11-02
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.